Where does Previvo Genetics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Previvo Genetics, Inc. ranks #21,626 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Previvo Genetics, Inc. hold?

Previvo Genetics, Inc. holds 13 US utility patents granted between 2015 and 2021, spanning 9 technology areas.

What is Previvo Genetics, Inc.'s Innovation Score?

Previvo Genetics, Inc. has an Innovation Score of 28.4 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Previvo Genetics, Inc. focus on?

Previvo Genetics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Previvo Genetics, Inc.'s patent grant rate increasing or decreasing?

Previvo Genetics, Inc.'s recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Previvo Genetics, Inc.'s patents?

Previvo Genetics, Inc.'s patents average 14.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Previvo Genetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Previvo Genetics, Inc.

USPTO PatentsView assignee record - 13 granted patents across 9 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Previvo ranks #21,626 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 9 technology areas.

#21,626
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.4/100): 14.5
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21626 · US Corporation #21,626 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,626/49,997
PHOTO-FINISH Plethora
CPC-NARROW A61B · 9 areas
INNOV-THIN 28.4/100
CLAIMS-RICH 14.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Plethora Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Previvo’s 28.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (32%) Velocity 0.0 pts (0%) Breadth 10.6 pts (37%) Claim depth 8.7 pts (31%)

Qualcomm Incorporated · highest

85
Previvo Genetics · this assignee

28
3D Lighting… · lowest

7

What this shows Previvo's Innovation Score is 28.4/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Previvo?

Each dot is one of Previvo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Previvo’s own 14.5 claims/patent is at or below the 19.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Previvo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Previvo's grants concentrate

Previvo Genetics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 84.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2015. By volume, Previvo sits between Plethora Corporation and Pro-Dex, Inc..

Plethora

13
Porex

13
Post Consumer Bra…

13
Precise Biometric…

13
Primos Storage Te…

13
Princeton Biochem…

13
Principle Power

13
Pro-dex

13
Previvo Genetics ◀

13

What this shows Previvo holds 13 patents at rank #21,629, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Previvo

By rank, the assignees closest to #21,629 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Previvo's primary technology class.

Previvo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Previvo Genetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.7%
2016	5	38.5%
2017	1	7.7%
2018	1	7.7%
2019	2	15.4%
2021	3	23.1%

Which technologies does Previvo Genetics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Previvo Genetics, Inc.'s patent record in context - here's where to go next.

Previvo Genetics, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 84.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #21,626 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Previvo Genetics, Inc. against Plethora Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.